Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a Canada-based pharmaceutical company. The Company is focused on the development and commercialization of therapies for the United States cardiovascular market. The focus of the Company is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company’s United States subsidiary, Medicure Pharma Inc. The Company also operates Marley Drug, Inc. (Marley Drug), a pharmacy located in North Carolina that offers an Extended Supply drug program serving all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving the health status of its patients and the communities they serve while reducing overall health care costs for employers and other health care consumers. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Post by eSnowdenon Oct 21, 2019 10:41am

180 Views

Post# 30250959

Blew through another 52 week low

what i said from the beginning, share buybacks don't work. worst case scenario is spending all the money from the apicore sale and having to dilute...which wastes all the share buybacks. the extra $10mm that mylan didn't pay and supposedly is guaranteed through insurance is questionable. given the yearly chart, sell-side has been heavily favored. majorly dissapointed in mph's performance.

Bullboard Posts

2024, a breakthrough year for silver